Medable

Digital platform for conducting clinical trials

Palo Alto, California, United States

About Medable

Medable provides a digital platform that simplifies the process of conducting clinical trials in the healthcare sector. Its main features include tools for onboarding participants, collecting data, sending study notifications, and offering real-time reporting. This platform digitizes the entire clinical trial process, making it easier for pharmaceutical companies and other organizations to gather high-quality data needed to validate their drugs or treatments. Medable stands out from competitors with its user-friendly design, scalability, and a strong decentralized clinical trial (DCT) network, which allows trials to be conducted remotely. The company aims to support the growing DCT market, which is projected to exceed $12 billion by 2030, by providing a platform that is accessible in over 60 countries and 120 languages.

Palo Alto, CaliforniaHeadquarters
2016Year Founded
$492.4MTotal Funding
SERIES_DCompany Stage
Enterprise Software, HealthcareIndustries
201-500Employees

Benefits

Health & wellness
401k
Remote first
Career development
Military support
Time away

Risks

Increased competition from AI-driven SaaS companies could threaten Medable's market share.
Dependency on Google Cloud may pose operational risks if disruptions occur.
Rapid AI adoption may lead to data privacy and security vulnerabilities.

Differentiation

Medable offers a unified platform for decentralized clinical trials, enhancing efficiency.
The platform supports over 60 countries and 120 languages, ensuring global reach.
Medable's integration with Google Cloud enhances scalability and accessibility for users.

Upsides

Medable AI reduces clinical trial startup time, offering a competitive advantage.
The no-code platform simplifies trial processes, leading to faster study go-live.
Winning the 2024 Prix Galien UK Award highlights Medable's innovation in digital health.

Funding

Total raised$492.39 M
Latest valuation$2.10 B
StageSERIES_D
LATE VC
4/30/2020
$25
$125.00 M
EARLY VC
1/31/2017
$5
$25.00 M
SERIES A
11/30/2015
$3
$16.00 M